Expression of Concern
After this article  was published, concerns were raised about undeclared competing interests, and about the study design and conclusions.
In response to the concerns about declaration of potential competing interests, the authors have provided the following update to the Competing Interests statement:
AJF is the Scientific Director and JY is the Technical Director of the Amino Acid Laboratory at the University of California, Davis (UCD) that provides amino acid analysis on a fee for service basis. AJF received remuneration for lectures or as an advisor on behalf of Nestlé Purina PetCare, Mars Petcare, Synergy Food Ingredients, the Mark Morris and Pet Food Institutes. AJF received funding from Nutro for graduate student training. A resident on the Nutrition Service, mentored in part by AJF, received funds from the Hill’s Pet Nutrition Resident Clinical Study Grants program, matched by the Center for Companion Animal Health, School of Veterinary Medicine at UCD. The Veterinary Medical Teaching Hospital at UCD received funding from Royal Canin to support a resident, and from Nestlé Purina PetCare to partially support a nutrition technician. AJF has a contract with the FDA on unrelated research. Since the time of article submission, JAS has received research support from Nature’s Variety Inc. Collectively, this did not influence the collection or interpretation of results in this study. There are no patents, products in development or marketed products to declare. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Concerns raised about the study are outlined below. The authors noted that some of these issues were discussed during pre-publication peer review and/or in the published article.
- Questions were raised around the criteria used to categorize diets, including about the rationale of including global company sales details in these criteria given the objectives of the study.
- Concerns were raised about potential confounds in the study, for example due to the inclusion of adult, puppy, and prescription-only foods, and due to inclusion of raw and kibble diets in the non-traditional group whereas the traditional group only included kibble.
- Soybeans are in the legume family, but soybeans and soy products were not considered as legumes for the purpose of categorizing diets in this study. The authors have requested a correction to clarify that this was an intentional exclusion, and they have noted that this aspect of the study design aligned with how soy products are being handled in a related FDA investigation.
- Questions were raised about the statistical analyses reported in the article.
- Reporting errors were noted, including errors in Tables 1 and 2, for which the authors requested a correction, and other issues raised to the journal that may impact categorization of some included foods as traditional versus non-traditional.
- Questions were raised as to whether three months on a given diet is a sufficient duration to impact cardiac/DCM outcomes, and whether diet history prior to a subject’s current diet may impact the study outcomes. Concerns were also raised about differences between groups in the average time on the current diet.
- Questions were raised about the validity of the conclusion statement, “Grain free diets, produced by small companies, including legumes within the top 5 ingredients represent a risk for the development of taurine deficiency and echocardiographic abnormalities consistent with DCM in the golden retriever.”
The article  is being reassessed in light of issues raised post-publication, and the journal is investigating the validity of the concerns raised as well as their implications for the reliability of the article’s conclusions. Meanwhile, the PLOS ONE Editors issue this Expression of Concern.
9 Sep 2020: The PLOS ONE Editors (2020) Expression of Concern: Development of plasma and whole blood taurine reference ranges and identification of dietary features associated with taurine deficiency and dilated cardiomyopathy in golden retrievers: A prospective, observational study. PLOS ONE 15(9): e0239078. https://doi.org/10.1371/journal.pone.0239078 View expression of concern
A surge in Food and Drug Administration (FDA) consumer complaints identified concerns that legume-rich, grain-free diets were associated with nutritionally-mediated dilated cardiomyopathy (DCM). Golden retrievers represent the most reported breed affected by this condition and previous studies documented the disease is responsive to dietary change and taurine supplementation. Although dietary findings across cases are compelling, prospective studies with control groups are lacking. The role of diet in developing taurine deficiency and echocardiographic changes consistent with DCM in healthy dogs is unknown.
We hypothesized that golden retrievers eating non-traditional diets are at a higher risk of having taurine deficiency and nutritionally-mediated DCM compared with those eating traditional commercial diets. We aimed to compare taurine concentrations and echocardiographic indices of systolic function between golden retrievers in each diet group and elucidate associations between diet and these variables. Additionally, we aimed to generate breed-specific reference intervals for whole blood and plasma taurine concentrations.
Golden retrievers eating traditional or non-traditional diets were evaluated and diet history, taurine concentrations and echocardiographic data were collected. Dietary features, taurine concentrations and echocardiographic findings were compared between diet groups. Relative risks were calculated for the likelihood of echocardiographic abnormalities and taurine deficiency in each diet group. Breed-specific reference intervals were constructed for taurine concentrations in dogs from the traditional diet group.
Golden retrievers eating non-traditional diets had significantly lower taurine concentrations and more frequent systolic dysfunction. Breed specific reference intervals are higher than previously reported across breeds.
Non-traditional diets, which were typically grain-free and contained legumes in this study, were significantly associated with and have increased relative risk for the identification of taurine deficiency and echocardiographic abnormalities consistent with nutritionally-mediated DCM. These findings were identifiable in the absence of clinical signs and support the findings of multiple previous studies and the ongoing FDA investigation.
Citation: Ontiveros ES, Whelchel BD, Yu J, Kaplan JL, Sharpe AN, Fousse SL, et al. (2020) Development of plasma and whole blood taurine reference ranges and identification of dietary features associated with taurine deficiency and dilated cardiomyopathy in golden retrievers: A prospective, observational study. PLoS ONE 15(5): e0233206. https://doi.org/10.1371/journal.pone.0233206
Editor: Francesco Staffieri, University of Bari, ITALY
Received: October 2, 2019; Accepted: April 19, 2020; Published: May 15, 2020
Copyright: © 2020 Ontiveros et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper and its Supporting Information files.
Funding: This study was supported by the Center For Companion Animal Health (CCAH) to JAS, the Maxine Adler Graduate Student Fellowship to ESO, The NIH T35 OD010956 Students Training in Advanced Research Fellowship to JAS and BDW, and the Amino Acid Laboratory at the University of California Davis to AJF.
Competing interests: A.J. Fascetti is the Scientific Director of and J. Yu is employed by the Amino Acid Laboratory at the University of California, Davis that provides amino acid analysis on a fee for service basis. This did not influence the collection or interpretation of results in this study. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Canine dilated cardiomyopathy (DCM) represents the second most common acquired heart disease in dogs and has multiple identified etiologies [1–3]. While DCM of genetic origins have been described for some breeds based upon discovered mutations or observed heritability and pattern of inheritance, determining etiology of DCM when observed outside of these breeds is challenging [4–16]. Nutritionally mediated DCM has been described across a variety of species including dogs and is most historically linked to taurine deficiency [17–27]. Recent peer-reviewed research on DCM in breeds that were not previously known to have a genetic etiology has raised concern about the relationship between diets with certain characteristics and the development of nutritionally-mediated DCM [28–30]. The Food and Drug Administration issued a warning and subsequently released data that identified dietary characteristics which were over-represented in consumer concern reports [31,32]. This data is supported by similar findings from researchers at multiple institutions and suggests that diets which are grain-free, contain legume or potato ingredients warrant study to further elucidate a possible role in the causation of DCM [28,29]. When evaluated, the FDA data also identifies an inverse relationship/correlation between the size of a company in terms of worldwide sales and the number of reported cases of DCM where smaller companies have the highest reported case numbers .
Of all breeds represented in the research and FDA report, the golden retriever is consistently the most frequently reported breed to be affected by nutritionally-mediated DCM [20,22,23,29,32]. The role of taurine deficiency in this breed appears more relevant when compared to other breeds eating similar diets [20,22,23,29]. The over-representation of golden retrievers is interesting as there is no literature to support any familial relationship or genetic etiology for classic DCM in golden retrievers. In fact, results of a large golden retriever breed club survey in 1999 showed the incidence of cardiomyopathy in >1400 golden retrievers to be less than 0.7% with no further classification information provided . Additionally, a large study of heart disease of insured dogs identified golden retrievers as a low risk breed for all cardiac claims and having a lower cardiac mortality rate than the pooled study population (8 compared to 22 respectively). Numerous reports have implicated that golden retrievers may be more susceptible to taurine deficiencies [20,22,23,29]. Thus, the investigators sought to study the relationship between diet and dietary ingredients with nutritionally-mediated DCM with or without taurine deficiency. The authors have previously reported on 24 cases of nutritionally-mediated DCM in golden retrievers and their response to therapy. This previous study demonstrated that dogs of this breed with clinical disease have a high likelihood of disease reversal when diet change and taurine supplementation is implemented . However, this previous study was a prospective clinical case series that followed patients over time and introduced new questions about the incidence of this disease in other populations and the role of diet and dietary ingredients in this disease process .
The objective of this study was to evaluate the incidence of nutritionally-mediated dilated cardiomyopathy in a population of healthy golden retrievers presented for breed screening evaluations. We hypothesized that golden retrievers eating what we defined as non-traditional commercial diets are at a higher risk of having taurine deficiency and nutritionally-mediated DCM than those eating what we defined as traditional commercial diets. We aimed to compare taurine concentrations in plasma and whole blood, echocardiographic indices of heart size and systolic function between golden retrievers in each diet group and elucidate any associations between diet group and these variables. Additionally, we aimed to compare reference intervals generated from the traditional diet group to those historically used from previous multi-breed studies.
Materials & methods
Golden retrievers were recruited for this prospective observation study from the populations of the cardiovascular breed screening examinations at the Cardiac Genetics Research Laboratory of the University of California Davis, breed screening events hosted by breed clubs or in response to the study advertisement on the university clinical trials webpage between the years of 2017 and 2019. Individuals identified as possible participants through one of these routes were offered the opportunity to participate in this research. The study was approved by the Institutional Animal Care and Use Committee of the University of California Davis and all study participants provided informed consent. Inclusion criteria required the dogs be free of any reported clinical signs of disease, have an unchanged diet history for at least 3 months, allow complete echocardiographic examination without the requirement for sedation and provide a complete diet history.
Treatment groups and diet history
Diet groups were defined and those not meeting either category were not enrolled in the study, but rather continued as clinical patients. Traditional diets (TD) were required to meet all of the following criteria: kibble diets which are grain-inclusive, not including legumes or potatoes in the top 5 ingredients listed and be produced by a pet food company with >$2billion in global sales for 2018. Non-traditional diets (NTD) had to meet one of the following criteria: kibble or raw food diet which is grain free, includes legumes or potatoes in the ingredient list, or is manufactured by a small pet food company with <$1billion in global sales for 2018. Publicly available global sales information of the parent company was used as previously reported [35,36]. These categories were defined a priori based upon reported FDA data and the authors clinical experience showing overlapping results that the disease is most frequently observed in dogs fed grain free diets with legumes or potatoes often in the top 5 positions of the ingredient list . It is further supported by the FDA data and the authors clinical experience that there is a relative absence of cases from large companies, particularly when compared to market share of the individual diets, where the most abundant cases reported were from companies with very small market share [32,36,37].
Enrollment targeted at least 40 dogs in each group to provide the ability to meet American Society for Veterinary Clinical Pathology (ASVCP) guidelines for the generation of reference intervals, thus once 40 dogs were met in each group the study enrollment was stopped . Body weight (kg) and sex and whether the dog was castrated, spayed or intact was recorded. Body condition score was assessed by the attending veterinary cardiologist and recorded using a validated 9-point scale . Muscle condition score was assessed by the attending veterinary cardiologist and recorded using a 4 point scale . A standardized diet history form (https://ccah.vetmed.ucdavis.edu/sites/g/files/dgvnsk4586/files/inline-files/Study_Related_Diet%20History_Form.pdf) was utilized for this study and verified for completeness prior to enrollment. When information was unclear at the time of data entry, the owners were contacted to provide additional details as needed. Data collected included brand names and varieties of the diet(s) fed at the time of sample collection. Daily quantity fed and length of time (months) the dog had been fed the same diet regimen was recorded. All medications, supplements or probiotics the dog was receiving were recorded. Dogs with diet histories not meeting one of the defined categories were excluded (i.e. dogs eating a mix of diets from the TD and NTD group, etc.). Dogs with incomplete diet histories that could not be elucidated through owner contact were excluded. Dogs that did not have a consistent diet history for >3 months were excluded. Dogs receiving supplements containing taurine, methionine or l-carnitine were excluded. Dogs receiving non-commercial foods that accounted for >10% of their diet were excluded. Dogs receiving canned pumpkin as a method to increase dietary fiber were excluded.
For each diet, the listed ingredients and calorie content (kcal/cup and kcal/kg) when available were reviewed and recorded. Diet data was recorded using archived website data within 6 months of the date of study enrollment when possible . When archived web data was not available, the diet data was obtained from the current internet listed product details at the time of data analysis (July 2019). For each diet, the inclusion of legumes or potatoes was recorded in several ways: 1) are any legume or potato ingredients within the top 5 ingredients listed, 2) are any legumes or potatoes in the diet ingredient list, 3) the total number of legumes or potatoes found in the ingredient list. Whether or not the diet was reported to be grain free was recorded and verified by review of the ingredient list. The inclusion of taurine or methionine in the ingredient list was recorded. Supplements reportedly administered were reviewed for the inclusion of taurine or methionine. If supplements were found to contain taurine or methionine the dog was excluded from the study.
Resting and maintenance energy requirements were calculated as previously reported . Resting energy requirement (RER) was calculated for each dog using the following equation: RER = 70 x BW0.75, where BW represents body weight in kilograms . Maintenance energy requirement (MER) was calculated as a range to provide the requirement for a sedentary to more active lifestyle . The MER calculation was performed by multiplying RER by 1.4 to 1.6 and providing the resulting range . Percent differences between the amount fed in kcal/day and the calculated MER range were calculated.
Blood taurine concentration measurements
Venous blood samples were obtained for lithium heparinized whole blood taurine (always >1mL) and plasma taurine (when possible >2mL) concentration measurements. Fasting was not required prior to blood sampling and fasted or fed status was not recorded. Fasting status does not impact taurine status in dogs . Samples were processed according to the guidelines of the Amino Acid Laboratory at UC Davis . Plasma taurine samples were not obtained for some study participants where screening exams took place off site and expedient plasma preparation and storage was not possible. Plasma taurine concentrations <60nmol/mL or whole blood taurine concentrations <200nmol/mL were considered low according to published canine reference intervals [45,46].
All dogs received an echocardiogram by a board-certified veterinary cardiologist or resident in training under the direct supervision of a board-certified veterinary cardiologist and images were stored for off-line analysis. Off-line echocardiographic image analysis and measurements were performed by a single investigator who was blinded to diet history and assigned diet group (Syngo Dynamic Workplace, Version 10.0.01_HF04_Rev5 [Build 2884], Siemens Medical Solutions, Malvern Pennsylvania). Complete echocardiographic examinations were reviewed with the intent to exclude any patients from the study that had congenital cardiac disease capable of negatively impacting systolic function or increasing chamber size. Echocardiographic measures recorded for the study included measurement of left ventricular internal diameter in diastole (LVIDd), left ventricular internal diameter in systole (LVIDs) and calculated percent fractional shortening (%FS). Briefly left ventricular measures were performed from right parasternal short-axis m-mode imaging of the left ventricle at the level of papillary muscles and measures were performed and averaged from 3 consecutive sinus beats when possible avoiding the cycles immediately following any observed arrhythmias. Fractional shortening was calculated from the measures by the following equation: (LVIDd-LVIDs)/LVIDd x 100. Ejection fraction was calculated using the Teichholz method to determine chamber volumes as previously described . End diastolic volume index and end-systolic volume index were also calculated by dividing the end-systolic or end-diatolic volumes in milliliters by body surface area in meters2 as previously described . Body surface area was calculated by the formula 0.101 x body weight (kg)2/3. The fractional shortening was recorded as low when <25% [49,50]; LVIDd was considered increased when >51 mm , and LVIDs was considered increased when >35 mm . These chosen cut-off values are based upon previously published data and breed specific reference intervals which also maintain consistency with prior publication[29,49,50].
Statistical analysis was performed with the use of commercially available software (GraphPad Prism version 8.2.1 for macOS, GraphPad Software, San Diego, California USA, www.graphpad.com; MedCalc Statistical Software version 16.4.3, MedCalc Software bvba, Ostend, Belgium; www.medcalc.org; 2016). Data was inspected visually for normal distribution and tested for normality by D’Agostino-Pearson omnibus normality test. Column statistics were provided for all continuous variables with parametric data reported as mean +/- standard deviation (SD) and non-parametric data reported as median and interquartile range. When applicable, range was reported as minimum (min) and maximum (max) values. Differences between groups were tested for statistical significance by use of an unpaired t-test (when both data groups were parametric) or Mann-Whitney test (when either or both data groups were non-parametric). A P value less than 0.05 was considered significant.
Two-by-two contingency tables were constructed for evaluation of categorical variable outcomes such as low taurine concentration, elevated left ventricular chamber dimension (LVIDd or LVIDs) or reduced fractional shortening classifying no as 0 and yes as 1. Statistical associations between diet groups (TD vs. NTD) were tested using a Fishers exact test and the relative risk and 95% confidence interval of the relative risk of these outcomes are reported.
For all enrolled dogs where both plasma and whole blood taurine concentrations were available the data was evaluated for correlation (Spearman correlation). Significant correlation (P<0.05) was described as weak correlation (R2<0.2), moderate correlation (R2 = 0.2–0.4) or strong correlation (R2>0.4).
Reference intervals were established for dogs in the TD group according to the Clinical and Laboratory Standards Institute guidelines for determining reference values and reference intervals for quantitative clinical laboratory tests . For normally distributed data, reference intervals were generated using commercially available software (MedCalc Statistical Software version 16.4.3, MedCalc Software bvba, Ostend, Belgium; www.medcalc.org; 2016) using the Robust method with 90% bootstrap confidence intervals of the reference limit reported and no outliers removed. For non-parametric data the reference intervals were generated using the nonparametric percentile technique with no outliers removed .
A total of 116 golden retrievers were considered for study inclusion. Twelve dogs were excluded for feeding a mix of TD and NTD. Twelve dogs were excluded for feeding a non-commercial food item that accounted for >10% of the daily calories in the diet. Four dogs were excluded for receiving supplements containing taurine methionine or l-carnitine. One dog was excluded for an inconsistent or unclear diet history over the 3 months preceding study enrollment. One dog was excluded for feeding food additives with intent of increasing dietary fiber (canned pumpkin). Eighty-six dogs remained after exclusions and were sorted into the TD (n = 43) and NTD (n = 43) groups. The investigators stopped study enrollment when the numbers met the predetermined level of >40 dogs per group.
The study was comprised of a total of 44 males (14 castrated) and 42 females (24 spayed). In the TD group there were 20 males (3 castrated) and 23 females (13 spayed). In the NTD group there were 24 male (11 castrated) and 19 females (11 spayed). The mean age +/- SD of the dogs was 4.1 +/-3.2 and 4.5 +/- 2.9 years respectively for the TD and NTD groups (P = 0.63). Body weight (mean +/- SD) was 28.9 +/- 4.9 and 31.1 +/- 4.7 for the TD and NTD groups respectively and was significantly higher in the NTD group (P = 0.04). Body condition score had a median of 5 (IQR 5, 6) in each group (P = 0.86). Muscle condition score was 4 for all enrolled dogs.
Whole blood and plasma taurine concentrations
Whole blood taurine concentrations were available for all dogs in the study. None of the plasma samples were visibly hemolyzed prior to measuring taurine concentrations. Plasma taurine concentrations were available for all 43 dogs in the TD group and 36 dogs in the NTD group. Whole blood taurine concentrations were significantly lower in the NTD group (mean +/- SD; 264 +/- 72.0 nmol/mL; range 55–473 nmol/mL) when compared to the TD group (297 +/- 47.4 nmol/mL; range 216–411 nmol/mL; P = 0.01) (Fig 1A). Plasma taurine concentrations were not significantly different between groups with means of 106 +/- 36.2 nmol/mL in the TD group and 102.1 +/- 34.0 nmol/mL in the NTD group (P = 0.85) (Fig 1B).
A) Unpaired t-test results for whole-blood taurine concentration (nmol/mL). The dash line at 200 nmol/ml denotes the current threshold for low whole-blood taurine concentration. B) Mann-Whitney test results for plasma taurine concentration (nmol/mL). The dashed line at 60 nmol/mL denotes the current threshold for low plasma taurine concentration.
Fractional shortening was lower in the NTD group (30.6 +/- 6.7%; range 13.1–46.0%) compared to the TD group (34.2 +/- 5.2%; range 25.3–46.8%; P = 0.006; Fig 2A). Left ventricular diameter in diastole was significantly increased in the NTD group (median 43.2, IQR 36.3, 47 cm, range 36.3–62.2 cm) compared to the TD group (median 41.1, IQR 39.2, 43.8 cm; range 34.3–49.3 cm; P = 0.009; Fig 2B). Left ventricular diameter in systole was significantly increased in the NTD group (median 30.0, IQR 26.0, 34.6 cm, range 22.0–51.7 cm) compared to the TD group (median 27.5, IQR 25.0, 29.4 cm; range 19.9–36.0cm; P = 0.003; Fig 2C). Ejection fraction was significantly lower in the NTD group (58 +/- 9.9%; range 34–77%) compared to the TD group (63 +/- 7.1%; range 50–79%; P = 0.007; S1A Fig). End-systolic volume index was significantly higher in the NTD group (median 36.2, IQR 26.9, 48.3, range 16.8–118.4) compared to the TD group (median 29.5, IQR 24.4, 34.2, range 13.1–62.4; P = 0.013; S1B Fig). End-diastolic volume index was not significantly different between the NTD group (median 84.3, IQR 77.2, 102.8, range 55.1–179.8) when compared to the TD group (median 79.9, IQR 73.0, 86.9, range 50.3–129.9; P = 0.061; S1C Fig).
A) Unpaired t-test results for m-mode fractional shortening (FS) percent for different diet groups. The dashed line at 25% denotes the study threshold for a low FS. B) Mann-Whitney test results for left ventricular internal diameter in diastole (LVIDd) in mm for different diet groups. The dashed line at 51mm denotes the study threshold for diagnosing an increased LVIDd. C) Mann-Whitney test results for left ventricular internal diameter in systole (LVIDs) in mm for different diet groups. The dashed line at 35mm denotes the study threshold for diagnosing an increased LVIDs.
Fisher’s exact testing identified that total instances of low taurine (either whole blood or plasma) were associated with feeding a NTD diet (P = 0.007). There were 9 instances of low whole blood or plasma taurine concentration in the NTD group compared to 1 in the TD group and 70 and 85 normal taurine concentration instances respectively resulting in a relative risk of 9.8 (95% CI 1.3–75.6, z statistic 2.2, P = 0.03) (Fig 3A). Diet characteristics for the TD and NTD groups are listed in Tables 1 and 2 respectively. Fisher’s exact testing identified low FS% was associated with feeding a NTD diet (P = 0.007). There were 7 instances of low FS% in the NTD group and 0 instances in the TD group with 36 and 43 normal FS% cases respectively resulting in a relative risk of 15.0 (95% CI 0.88–254.7, z statistic 1.87, P = 0.06) (Fig 3B). Fisher’s exact testing identified that an elevated LVIDs was associated with the NTD diet group (P = 0.01). There were 9 instances of increased LVIDs in the NTD group and 1 instance in the TD group with 34 and 42 normal LVIDs measurements respectively resulting in a relative risk of 9.0 (95% CI 1.2–68.0, z statistic 2.13, P = 0.03) (Fig 3C). Fisher’s exact testing did not reveal a significant association between diet group and increased LVIDd (P = 0.06). There were 5 instances of elevated LVIDd measures in the NTD group and 0 instances of elevated LVIDd measures in the TD group with 38 and 43 normal LVIDd measurements respectively resulting in a relative risk of 11 (95% CI 0.63 to 193.0, z statistic 1.64, P = 0.10) (Fig 3D). Diet brand, variety, instances of low taurine events and the identified echocardiographic changes indicative of systolic dysfunction are listed in Tables 3 and 4 for dogs eating a TD and NTD respectively.
Forest plots illustrating the relative risk for consuming a traditional (TD) and non-traditional (NTD) diet for A) low whole-blood or plasma taurine, B) decreased fractional shortening (FS) percent, C) increased left ventricular internal diameter in systole (LVIDs), and D) increased left ventricular internal diameter in diastole (LVIDd).
For the 79 dogs where both whole blood and plasma taurine concentrations were available, Spearman correlation evaluation revealed a significant moderate correlation (P<0.0001; r = 0.52, r2 = 0.27) (Fig 4).
Food intake & time on diet
Dogs in both groups were typically fed fewer calories when compared to sedentary or active MER calculations. The median percent difference between the number of calories fed and the calculated sedentary or active energy requirements was -19.9% (IQR -36.7, 14.0) and -30.0% (IQR -44.6, -0.30) respectively for the TD group. The median percent difference between the amount fed and the calculated sedentary or active energy requirements was -20.0% (IQR -34.2, -13.32) and -30.0% (IQR -42.4, -24.2) respectively for the NTD group. No difference was identified when comparing the TD to the NTD group for either sedentary (P = 0.38) or active (P = 0.38) MER calculations (Fig 5). Diet calculations are shown for the TD and NTD groups in Tables 5 and 6 respectively. The median number of months a dog was fed a diet was shorter in the TD group with a median of 7 (IQR 5.0, 21.0) compared to the NTD group with a median of 18 (IQR 9.0, 36.0; P = 0.006). There were a total of 6 dogs in the TD group and 1 dog in the NTD group that were fed their diet for the minimum of 3 months prior to study enrollment.
Whole blood and plasma taurine reference intervals
Whole blood and plasma taurine reference ranges were generated using the TD diet group which included 43 dogs with normal echocardiographic examinations. For whole blood the robust methodology with 90% bootstrap confidence intervals resulted in a reference interval of 213 to 377 nmol/mL (90% CI lower limit 198 to 230 and upper limit 355 to 396) (Fig 6). For plasma taurine concentration the nonparametric percentile method resulted in a reference interval of 63 to 194 nmol/mL (Fig 7).
Although the dietary link between low taurine concentration and dilated cardiomyopathy has been described and understood for many years, a recent FDA alert identified an emerging nutritionally-mediated cardiomyopathy in dogs [31,32]. Of the dogs reported by the FDA, the golden retriever is the most over-represented . Additionally, a clinical case series of golden retrievers with nutritionally-mediated dilated cardiomyopathy was published that confirmed the dietary features that the FDA noted to be most frequently observed in affected dogs . Until now, an association between grain free diets containing legumes had not been identified as previous reports lacked the necessary control group or were retrospective in nature [28,29].
In this study we identified that golden retrievers eating diets with certain characteristics (NTD group) are at a higher risk of having low taurine concentrations and/or echocardiographic abnormalities supportive of dilated cardiomyopathy when compared to a control group eating TD. The characteristics of the NTD group were specifically chosen based upon identified diet features that are associated with recent reports of cases of nutritionally-mediated dilated cardiomyopathy [28,29,31,32]. These features include being labeled as grain free, containing pulse ingredients like legumes (peas, lentils, etc.) or potatoes, and being produced by a small company as market share appears inversely proportional to the number of reported cases in the FDA consumer complaint dataset. The control group (TD group) was selected to avoid these features and required the company producing the product to be large as previously defined , not include pulse ingredients within the top 5 dietary ingredients, be grain inclusive and be a dry kibble diet.
This study also identified that regardless of diet group, golden retrievers are on average fed fewer calories relative to the commonly accepted MER for sedentary or active dogs. This finding was observed in a previous publication and was hypothesized to possibly play a role in the development of nutritionally-mediated DCM . The data in the current study argues that being fed below MER is not a significant factor in the development of low taurine concentrations or echocardiographic abnormalities as feeding below MER was no different between the TD and NTD groups.
Golden retrievers have been previously reported to have taurine-deficient dilated cardiomyopathy and it has been speculated that they may be a more sensitive breed for developing this condition [20,22,23,29]. However, the golden retriever is not a breed with a demonstrated heritable form of dilated cardiomyopathy and until now the number of cases of golden retrievers with DCM in the literature is low, particularly given the breeds extreme popularity [1,2,52–55]. These features make a genetic form of dilated cardiomyopathy within the golden retriever breed exceedingly unlikely. The implication that they may be more sensitive as a breed to taurine deficiency prompted the authors to use the control group (TD group) of this study to construct reference intervals. The reference intervals identified through this study show that the golden retriever may have a slightly higher taurine concentration in health when compared to previous multi-breed studies and the currently adopted reference intervals from the testing laboratory [45,46]. Although the number of golden retrievers used for this reference interval was moderate (n = 43) it is possible that a more robust reference interval cohort may alter the results and as such this recommendation should be critically evaluated. It is also important to observe that in this study the whole blood taurine and not plasma taurine concentrations were significantly lower in the NTD group when compared to the TD group. This discrepancy could be secondary to the sensitivity for erroneously elevated plasma taurine concentrations when hemolysis or other microscopic cellular contamination is observed. Hemolysis is not the only change that can impact plasma taurine concentrations. Platelets present the highest taurine concentrations among cells due to three different types of transporters with varying affinities . Taurine is also the most abundant single amino acid in leukocytes . Taken together, falsely elevated plasma taurine concentrations can arise from any of the above-mentioned cells [56–58]. Although gross hemolysis was not observed in any of the plasma samples in this study, the impact of sample handling and plasma contamination with cells must be considered.
This clinical study has a number of limitations that should be considered. The first is that the authors only analyzed the owner-reported diet history and the dog’s biochemical and echocardiographic data. Thyroid function was not evaluated in this study. Hypothyroidism may influence food intake, body weight and muscle condition, but this variable was not evaluated in this study. Hypothyroidism has also long been considered a variable that may contribute to reduced systolic function . However, recent studies confirm that the key variables of systolic function and chamber dilation measured in this study (FS, LVIDd and LVIDs) were not significantly different between dogs with untreated hypothyroidism and control dogs . Significant hypothyroidism is not expected in any of the study participants, as they were free of clinical signs of this condition. Additionally, more rigorous screening tests were not performed as they were determined to be beyond the scope and budget of this study. While the yield of these diagnostic tests in patients without clinical signs is expected to be low, future studies may consider parasite testing, biochemical profiles, cardiac biomarkers, infectious disease testing, ambulatory electrocardiography monitoring and complete blood counts as part of the health screening at time of enrollment. These additional screening tests may be helpful in ruling out rare conditions that may contribute to reduced systolic function. No diet samples were collected or tested in this study. While analysis of the sulfur amino acid content of the diets may have yielded some insights, quantitative analysis of methionine and cysteine does not provide information about the digestibility and bioavailability of these amino acids in the diet. Evaluating the diets by conducting digestibility and bioavailability studies, and comparing findings to patient data may represent future directions for evaluating this condition. Additionally, the diet ingredient data and evaluation of diet characteristics were collected upon completion of the study from Internet archives . When available, the Internet archive closest to the date of examination was used, however, many of the diets did not have archived pages for evaluation. This leads to the possibility that some foods formulations may have changed during the study period, perhaps even in response to previous publications of FDA alerts [28,29,31,32]. The diet histories of the NTD group in particular are highly variable and reflect current feeding practices in healthy golden retrievers. Many dogs were being fed a mix of multiple diets, which limited the authors’ ability to make energy calculations and derive data that could be determined as the result of specific diets. Instead, the authors evaluated the TD and NTD group as a whole and have summarized features of this diet group rather than associated results to individual diets. Certainly, the findings of this study cannot be applied to every diet meeting these dietary characteristics and future controlled diet trial studies may offer additional insight into disease causation. The requirements for study enrollment mandated that dogs be fed a consistent diet for at least three months, which the vast majority of dogs greatly exceeded. However, there were seven dogs that were fed their diet for the minimum enrollment criteria of 3 months. It is possible that previous diet history may have impacted echocardiographic results and these previous diet histories were not obtained or analyzed as part of this study. The time it takes for diet change to induce or reverse changes in systolic function are not known in the dog, particularly in light of this currently observed nutritionally-mediated cardiomyopathy. This represents a limitation of the study that could be avoided in future long-term studies or through continued follow-up examinations. The chosen three month stable diet requirement is however, more than adequate to observe taurine level depletion and repletion based upon a previous study where plasma taurine concentration changes were observed after as little as 5 weeks. Finally, this study provided only a single evaluation of these patients and did not evaluate disease progression or outcome. Future studies evaluating response to grain free diets produced by the larger manufacturers and diet change in a controlled environment would be a valuable addition to the literature as we strive to understand this emerging issue of nutritionally-mediated DCM.
The current study affirmed our hypothesis and further validates the findings of multiple previous studies and the FDA alert [28–32]. Grain free diets, produced by small companies, including legumes within the top 5 ingredients represent a risk for the development of taurine deficiency and echocardiographic abnormalities consistent with DCM in the golden retriever. Golden retriever specific reference intervals for whole blood and plasma taurine concentrations are proposed. Further research to evaluate these findings in additional dog breeds and elucidate the causative mechanisms behind these results is indicated.
S1 Fig. Results for echocardiographic variable differences for traditional and non-traditional diet groups.
A) Unpaired t-test results for ejection fraction percent for different diet groups. B) Mann-Whitney test results for end-systolic volume index for different diet groups. C) Mann-Whitney test results for end-diastolic volume index for different diet groups.
- 1. Meurs KM. Insights into the hereditability of canine cardiomyopathy. Vet Clin North Am Small Anim Pract. United States; 1998;28: 1449–57, viii. pmid:10098247
- 2. O’Grady MR, O’Sullivan ML. Dilated cardiomyopathy: an update. Vet Clin North Am Small Anim Pract. United States; 2004;34: 1187–1207. pmid:15325477
- 3. Freeman LM, Rush JE. Nutrition and cardiomyopathy: lessons from spontaneous animal models. Curr Heart Fail Rep. United States; 2007;4: 84–90. pmid:17521500
- 4. Stern JA, Ueda Y. Inherited cardiomyopathies in veterinary medicine. Pflügers Arch J Physiol. Springer; 2018; 1–9.
- 5. Yost O, Friedenberg SG, Jesty SA, Olby NJ, Meurs KM. The R9H phospholamban mutation is associated with highly penetrant dilated cardiomyopathy and sudden death in a spontaneous canine model. Gene. Netherlands; 2019;697: 118–122. pmid:30794913
- 6. Harmon MW, Leach SB, Lamb KE. Dilated Cardiomyopathy in Standard Schnauzers: Retrospective Study of 15 Cases. J Am Anim Hosp Assoc. United States; 2017;53: 38–44. pmid:27841675
- 7. Martin MWS, Stafford Johnson MJ, Celona B. Canine dilated cardiomyopathy: a retrospective study of signalment, presentation and clinical findings in 369 cases. J Small Anim Pract. England; 2009;50: 23–29. pmid:19037887
- 8. Wiersma AC, Stabej P, Leegwater PAJ, Van Oost BA, Ollier WE, Dukes-McEwan J. Evaluation of 15 candidate genes for dilated cardiomyopathy in the Newfoundland dog. J Hered. United States; 2008;99: 73–80. pmid:17998275
- 9. Meurs KM, Stern JA, Sisson DD, Kittleson MD, Cunningham SM, Ames MK, et al. Association of dilated cardiomyopathy with the striatin mutation genotype in boxer dogs. J Vet Intern Med. United States; 2013;27: 1437–1440. pmid:24033487
- 10. Meurs KM, Miller MW, Wright NA. Clinical features of dilated cardiomyopathy in Great Danes and results of a pedigree analysis: 17 cases (1990–2000). J Am Vet Med Assoc. United States; 2001;218: 729–732. pmid:11280406
- 11. Legge CH, Lopez A, Hanna P, Cote E, Hare E, Martinson SA. Histological characterization of dilated cardiomyopathy in the juvenile toy Manchester terrier. Vet Pathol. United States; 2013;50: 1043–1052. pmid:23456967
- 12. Meurs KM, Friedenberg SG, Kolb J, Saripalli C, Tonino P, Woodruff K, et al. A missense variant in the titin gene in Doberman pinscher dogs with familial dilated cardiomyopathy and sudden cardiac death. Hum Genet. Germany; 2019;138: 515–524. pmid:30715562
- 13. Meurs KM, Lahmers S, Keene BW, White SN, Oyama MA, Mauceli E, et al. A splice site mutation in a gene encoding for PDK4, a mitochondrial protein, is associated with the development of dilated cardiomyopathy in the Doberman pinscher. Hum Genet. Germany; 2012;131: 1319–1325. pmid:22447147
- 14. Simpson S, Dunning MD, Brownlie S, Patel J, Godden M, Cobb M, et al. Multiple Genetic Associations with Irish Wolfhound Dilated Cardiomyopathy. Biomed Res Int. United States; 2016;2016: 6374082. pmid:28070514
- 15. Werner P, Raducha MG, Prociuk U, Sleeper MM, Van Winkle TJ, Henthorn PS. A novel locus for dilated cardiomyopathy maps to canine chromosome 8. Genomics. United States; 2008;91: 517–521. pmid:18442891
- 16. Dambach DM, Lannon A, Sleeper MM, Buchanan J. Familial dilated cardiomyopathy of young Portuguese water dogs. J Vet Intern Med. United States; 1999;13: 65–71. pmid:10052066
- 17. Pion PD, Kittleson MD, Rogers QR, Morris JG. Myocardial failure in cats associated with low plasma taurine: a reversible cardiomyopathy. Science. United States; 1987;237: 764–768. pmid:3616607
- 18. Hayes KC. Taurine nutrition. Nutr Res Rev. England; 1988;1: 99–113. pmid:19094361
- 19. Marie-Claude B. Echocardiography. In: Ettinger SJ, Feldman EC CE, editor. Textbook of Veterinary Internal Medicine. Eighth Edi. Philadelphia: WB Saunders; 2000. pp. 393–410.
- 20. Kramer GA, Kittleson MD, Fox PR, Lewis J, Pion PD. Plasma taurine concentrations in normal dogs and in dogs with heart disease. J Vet Intern Med. United States; 1995;9: 253–258. pmid:8523322
- 21. Pion PD, Sanderson SL, Kittelson MD. The effectiveness of taurine and levocarnitine in dogs with heart disease. Vet Clin North Am Small Anim Pract. United States; 1998;28: 1495–514, ix. pmid:10098250
- 22. Belanger MC, Ouellet M, Queney G, Moreau M. Taurine-deficient dilated cardiomyopathy in a family of golden retrievers. J Am Anim Hosp Assoc. United States; 2005;41: 284–291. pmid:16141179
- 23. Fascetti AJ, Reed JR, Rogers QR, Backus RC. Taurine deficiency in dogs with dilated cardiomyopathy: 12 cases (1997–2001). J Am Vet Med Assoc. United States; 2003;223: 1137–1141. pmid:14584743
- 24. Kittleson MD, Keene B, Pion PD, Loyer CG. Results of the multicenter spaniel trial (MUST): taurine- and carnitine-responsive dilated cardiomyopathy in American cocker spaniels with decreased plasma taurine concentration. J Vet Intern Med. United States; 1997;11: 204–211. pmid:9298474
- 25. Backus RC, Cohen G, Pion PD, Good KL, Rogers QR, Fascetti AJ. Taurine deficiency in Newfoundlands fed commercially available complete and balanced diets. J Am Vet Med Assoc. United States; 2003;223: 1130–1136. pmid:14584742
- 26. Freeman LM, Michel KE, Brown DJ, Kaplan PM, Stamoulis ME, Rosenthal SL, et al. Idiopathic dilated cardiomyopathy in Dalmatians: nine cases (1990–1995). J Am Vet Med Assoc. United States; 1996;209: 1592–1596. pmid:8899024
- 27. Sanderson SL. Taurine and carnitine in canine cardiomyopathy. Vet Clin North Am Small Anim Pract. United States; 2006;36: 1325–43, vii–viii. pmid:17085238
- 28. Adin D, DeFrancesco TC, Keene B, Tou S, Meurs K, Atkins C, et al. Echocardiographic phenotype of canine dilated cardiomyopathy differs based on diet type. J Vet Cardiol. Netherlands; 2019;21: 1–9. pmid:30797439
- 29. Kaplan JL, Stern JA, Fascetti AJ, Larsen JA, Skolnik H, Peddle GD, et al. Taurine deficiency and dilated cardiomyopathy in golden retrievers fed commercial diets. PLoS One. United States; 2018;13: e0209112. pmid:30543707
- 30. Freeman LM, Stern JA, Fries R, Adin DB, Rush JE. Diet-associated dilated cardiomyopathy in dogs: what do we know? J Am Vet Med Assoc. United States; 2018;253: 1390–1394. pmid:30451613
- 31. Administration USF& D. FDA Investigating potential connection between diet and cases of canine heart disease [Internet]. [cited 23 Jul 2018]. Available: https://www.fda.gov/animalveterinary/newsevents/cvmupdates/ucm613305.htm
- 32. Administration USF& D. FDA Investigation into Potential Link between Certain Diets and Canine Dilated Cardiomyopathy [Internet]. [cited 27 Jun 2019]. Available: https://www.fda.gov/animal-veterinary/news-events/fda-investigation-potential-link-between-certain-diets-and-canine-dilated-cardiomyopathy
- 33. Larry Glickman, Nita Glickman & RT. The Golden Retriever Club of America National Health Survey 1998–1999. In: Golden Retriever Club of America National Health Survey [Internet]. 1998 [cited 9 Apr 2019]. Available: https://www.grca.org/wp-content/uploads/2015/08/healthsurvey1.pdf?fbclid=IwAR2xESDHDcsSI5Nb13E3ZTFmu9gB51yX-HF8ZXFaAEB5sJyJmAte1Cwp5Yo
- 34. Egenvall A, Bonnett BN, Häggström J. Heart disease as a cause of death in insured Swedish dogs younger than 10 years of age. J Vet Intern Med. Wiley Online Library; 2006;20: 894–903. pmid:16955814
- 35. Markovich JE, Freeman LM, Heinze CR. Analysis of thiamine concentrations in commercial canned foods formulated for cats. J Am Vet Med Assoc. United States; 2014;244: 175–179. pmid:24378026
- 36. Top Pet Food Companies Current Data [Internet]. 2018 [cited 8 Jan 2019]. Available: https://www.petfoodindustry.com/directories/211-top-pet-food-%0Acompanies/top_companies_table
- 37. International E. Country Report Dog Food in USA [Internet]. 2019. Available: https://www.euromonitor.com/dog-food-in-the-us/report
- 38. Friedrichs KR, Harr KE, Freeman KP, Szladovits B, Walton RM, Barnhart KF, et al. ASVCP reference interval guidelines: determination of de novo reference intervals in veterinary species and other related topics. Vet Clin Pathol. United States; 2012;41: 441–453. pmid:23240820
- 39. Laflamme D. Development and validation of a body condition score system for dogs.: a clinical tool. Canine Pr. 1997;22: 10–15.
- 40. Freeman LM, Michel KE, Zanghi BM, Vester Boler BM, Fages J. Evaluation of the use of muscle condition score and ultrasonographic measurements for assessment of muscle mass in dogs. Am J Vet Res. Am Vet Med Assoc; 2019;80: 595–600. pmid:31140851
- 41. Archive I. WayBack Machine [Internet]. 1996 [cited 9 Apr 2019]. Available: https://archive.org/web/
- 42. Ramsey JJ. Determining Energy Requirements. In: SJ FA and D, editor. Applied Veterinary Clinical Nutrition. 1st ed. Iowa: Wiley-Blackwell; 2012. pp. 23–45.
- 43. Gray K, Alexander LG, Staunton R, Colyer A, Watson A, Fascetti AJ. The effect of 48-hour fasting on taurine status in healthy adult dogs. J Anim Physiol Anim Nutr (Berl). Germany; 2016;100: 532–536. pmid:26250395
- 44. Medicine D of MB of the S of VU of C. The Amino Acid Laboratory [Internet]. [cited 9 Apr 2019]. Available: https://www.vetmed.ucdavis.edu/labs/amino-acid-laboratory
- 45. Torres CL, Backus RC, Fascetti AJ, Rogers QR. Taurine status in normal dogs fed a commercial diet associated with taurine deficiency and dilated cardiomyopathy. J Anim Physiol Anim Nutr (Berl). Germany; 2003;87: 359–372.
- 46. Delaney SJ, Kass PH, Rogers QR, Fascetti AJ. Plasma and whole blood taurine in normal dogs of varying size fed commercially prepared food. J Anim Physiol Anim Nutr (Berl). Germany; 2003;87: 236–244.
- 47. Scollan KF, Stieger-Vanegas SM, Sisson DD. Assessment of left ventricular volume and function in healthy dogs by use of one-, two-, and three-dimensional echocardiography versus multidetector computed tomography. Am J Vet Res. Am Vet Med Assoc; 2016;77: 1211–1219. pmid:27805446
- 48. Knight DH. No Title. In: Feldman SJE and EC, editor. Textbook of Veterinary Internal Medicine. 5th ed. Philadelphia, PA, USA; 1995. pp. 844–867.
- 49. Morrison SA, Moise NS, Scarlett J, Mohammed H, Yeager AE. Effect of breed and body weight on echocardiographic values in four breeds of dogs of differing somatotype. J Vet Intern Med. United States; 1992;6: 220–224. pmid:1522552
- 50. Cornell CC, Kittleson MD, Della Torre P, Haggstrom J, Lombard CW, Pedersen HD, et al. Allometric scaling of M-mode cardiac measurements in normal adult dogs. J Vet Intern Med. United States; 2004;18: 311–321. pmid:15188817
- 51. CLSI. Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline—Third Edition. In: CLSI document EP28-A3c [Internet]. Wayne, PA: Clinical and Laboratory Standards Institute; 2008 [cited 9 Apr 2019]. Available: https://clsi.org/media/1421/ep28a3c_sample.pdf
- 52. Borgarelli M, Santilli RA, Chiavegato D, D’Agnolo G, Zanatta R, Mannelli A, et al. Prognostic indicators for dogs with dilated cardiomyopathy. J Vet Intern Med. United States; 2006;20: 104–110. pmid:16496929
- 53. Monnet E, Orton EC, Salman M, Boon J. Idiopathic dilated cardiomyopathy in dogs: survival and prognostic indicators. J Vet Intern Med. United States; 1995;9: 12–17. pmid:7891357
- 54. Martin MWS, Stafford Johnson MJ, Strehlau G, King JN. Canine dilated cardiomyopathy: a retrospective study of prognostic findings in 367 clinical cases. J Small Anim Pract. England; 2010;51: 428–436. pmid:20670255
- 55. Meurs KM. Genetics of cardiac disease in the small animal patient. Vet Clin North Am Small Anim Pract. United States; 2010;40: 701–715. pmid:20610020
- 56. Paasonen MK, Solatunturi E, Nieminen ML. Blood platelets: accumulation and release of taurine. Prog Clin Biol Res. 1985;179: 225–233. pmid:4059215
- 57. Fukuda K, Hirai Y, Yoshida H, Nakajima T, Usui T. Free amino acid content of lymphocytes nd granulocytes compared. Clin Chem. Clinical Chemistry; 1982;28: 1758–1761. pmid:7094296
- 58. SC Z, QR. R. The use of plasma amino acid concentrations in the diagnosis of nutritional and metabolic disease in veterinary medicine. In: J.J.Kaneko, editor. Proceedings of the IV Congress of the International Society of Animal Clinical Biochemistry. University of CA, Davis; 1990. pp. 107–121.
- 59. Guglielmini C, Berlanda M, Fracassi F, Poser H, Koren S, Baron Toaldo M. Electrocardiographic and echocardiographic evaluation in dogs with hypothyroidism before and after levothyroxine supplementation: A prospective controlled study. J Vet Intern Med. Wiley Online Library; 2019